Allianz Asset Management
DSCI

Allianz Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Allianz Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,485
Closed -$237K – 2448
2014
Q2 		$237K Sell
20,485
-2,115
-9% -$21.7K ﹤0.01% 1764
2014
Q1 		$287K Hold
22,600
– – ﹤0.01% 1700
2013
Q4 		$245K Hold
22,600
– – ﹤0.01% 1679
2013
Q3 		$280K Hold
22,600
– – ﹤0.01% 1623
2013
Q2 		$302K Buy
+22,600
New +$291K ﹤0.01% 1562

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Allianz Asset Management's DSCI Position: Q3 2014 in Review

Allianz Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 20,485 shares — an estimated $237K sold.

Allianz Asset Management first reported a position in DSCI in Q2 2013 and held it in 5 quarters. The position peaked at $302K in Q2 2013. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Allianz Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Allianz Asset Management sold 20,485 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $237K.
  • Allianz Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 5 quarters.
  • Allianz Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $302K in Q2 2013.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Allianz Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.